The issue of placental transport of thyroid hormones has been debated for years. It was previously thought that there was minimal placental transport of these hormones in humans and in rats. This was attributed either to poor permeability of the fetal membranes andlor to active deiodinating mechanisms (1) (2) (3) (4) . Recent data, however, have shown that the rat placenta actively metabolizes T, to T, and that thyroid hormones do cross the placenta in both humans and rats, so that the placenta acts only as a limited barrier (5-8).
We have shown that maternal-fetal transport of T, in humans does not suffice to prevent in utero hypothyroidism (9) .
This conclusion is based on the observation that neonates with athyreotic congenital hypothyroidism are often born with more severe signs of hypothyroidism in the absence of epiphysial ossification centers and with extremely high TSH levels at birth. It has been claimed that maternal transfer of T, could still provide the fetal brain with sufficient T, to avoid major irreversible CNS damage if the fetal thyroid is not functional (5).
These authors suggested that the fetal brain might be protected by maternal T,, even if the transfer is not sufficient to protect other tissues, and that delayed skeletal maturation does not necessarily imply that the brain was T, deficient in utero. However, the very high TSH levels evident already at birth suggest that the fetal pituitary lacks T, for negative feedback. Several studies have shown that congenitally hypothyroid newborns with the most retarded bone maturation and with the lowest T, levels at screening have the poorest prognosis for CNS development, despite prompt postnatal treatment with T, (10) (11) (12) (13) . These results imply that maternal T, transfer fails to provide adequate prevention of in utero CNS developmental delay.
Although several studies support the existence of maternalfetal T, transfer in rats, T, was administered in these studies invasively, either intraperitoneally or through s.c. osmotic pumps. This could potentially produce a considerable degree of prenatal stress. Furthermore, none of these studies has followed the fetuses to birth. It would be of great value to have a rat model of in utero hypothyroidism in which the T, treatment is administered orally without traumatic manipulation of the pregnant dam and the postnatal development of the pups could be assessed. We have previously reported on the efficacy of using blood spotted on filter paper for T, measurement in the follow-up of children with congenital hypothyroidism (14) . In the present study we applied this method, which requires only a drop of blood, to measure T, in pregnant, postpartum, and newborn rats. In addition, we considered it of interest to study whether T, administered to the dam reaches the fetus during gestation and can correct the fetal hypothyroxinemia.
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METHODS
Arzimals and experimental design. Spraguc-Dawley rats from the colony at the Developmental Psychobiology Laboratory in the Psychology Department at Bar-Ilan University were mated in polycarbonate cages (38 X 30 X 27 cm) with grid floors. Cages were checked daily, and the day in which a vaginal plug was secreted and detected was considered d 1 of gestation (G-1). Parturition occurred between G-21 and G-23. Pregnant rats were housed individually in polycarbonate cages (38 X 30 X 27 cm) with stainless steel wire lids and wood shavings as bedding material. Food and tap water were continuously available in the cagc top. Lights in the colony were on from 0500 to 1900 h and temperature was maintained between 21 and 25°C. All conditions and treatments were in accordance with recommended humane conditions.
In experiment 1, the pregnant dams were divided into three experimental groups: MMI [l-methylimidazole-2-thiol, which crosses the placenta and blocks both maternal and fetal thyroid function (15); Sigma Chemical Co.] treated (n = 9), MMI + T, treated (n = lo), and controls (n = 11). Two of these groups were given 0.02% MMI (as in Ref. 16) as drinking water from G-10 to parturition. The third group (controls) received unaltered drinking water throughout prcgnancy. From G-16 to term all rats received daily i.p. injections. One of the MMI-treated groups rcccivcd 18 pg/kg body weight levothyroxine sodium (Synthroid, Boots Pharmaceuticals, Inc., Lincolnshire, IL), whereas the other two groups (MMI and control) received 0.9% saline. Injection volume was 1 mL/kg body weight. In experiment 2, the dose of T, was increased to ensure sufficient delivery by the oral route, and the MMI dose was increased in an effort to maximize its effect. Pregnant rats drank tap water until d G-9. From G-10 until parturition they received either I ) tap water, 2) MMI (0.04%), or 3) MMI (0.04%) and L-T4 (50 pg/100 mL solution, mean daily intake = 52.6 i 1.6 pg/kg body weight).
Tail blood spotted on filter paper was collected from the dams in experiment 1 on three occasions: before mating, on G-15, and within 1-16 h after parturition, and in experiment 2 on two occasions: before mating and after parturition. In both experiments within 1-16 h after parturition, trunk blood was collected after decapitation from two newborn pups (one male and one female) from each dam and spotted on filter paper (with special care not to include body fluids).
Measures and statistical aizalysis. After drying, all filter paper blood samples were kept in a cool, dark place. Samples from each experiment were assayed in duplicate, in a single assay in the National Screening Laboratory for Congenital Hypothyroidism, at the Sheba Medical Center. The Neonatal RIA kit for T, (DPC, Los Angeles, CA) was used (14) . The kit's buffer contains a high concentration of T, displacing agents (from albumin and thyroid binding globulin, details not provided by the manufacturer). This, according to the manufacturer, together with the buffer's high ionic strength (which precludes red blood cells from interfering with the assay), allows measurement of T, in a variety of animal species with this kit. The assay's sensitivity is 0.05 pg/dL. The assay's reliability for rat data were examined in a number of ways. First, intraassay reliability was studied by comparing the T, levels assessed from duplicates from the same blood spots examined in a single assay. The mean intraassay CV of the RIA was between 8 and 12% on separate runs. The results for experiment 1 showed r = 0.88, p < 0.01 for a sample of 17 postpartum rats and r = 0.73, p < 0.01 for a sample of 38 ncwborn rat pups, and in experiment 2 the correlation bctwecn the duplicates from 20 dams (almost all assessed twice at different times, n = 39 pairs of duplicates) was r = 0.94 ( p < 0.01), and from 42 newborn pups r = 0.89 ( p < 0.01). Second, interassay (or test-retest) reliability was assessed by reexamining the blood spots from 12 rats (four postpartum and eight newborn pups) 1 wk later. The results showed a r = 0.90 ( p < 0.01; mean T, level = 1.11 pg/dL, mean CV = 14.44%; this CV is similar to those reported for interasssay reliability of rat serum T, [mean CV = between 9.6 and 20.7%) assessed by the Coat-A-Count Total T, kit (DPC)]. And third, T, levels assessed from serum and from filtcr paper were highly correlated (r = 0.88, p < 0.001; based on pups from 19 litters). The T, levels ranged from 0.53 to 3.16 pg/dL, which is around the absolute range of the (euthyreotic) female Sprague-Dawley rat T, (0.8-4.8 pgIdL) assessed by the Coat-A-Count Total T, kit (DPC).
Maternal body weight during gestation and the newborn pups' weight, length, number, and sex ratio wcrc recorded. All the results were analyzed by analysis of variance with post hoc contrasts and Duncan's multiple range tests when required (1 7).
RESULTS
Maternal T, Levels
Experiment 1. The blood T, level in the three groups did not differ before mating, but on G-16, both MMI-treated groups showed significantly lower levels than controls (F (2,26) = 14.83, 17 < 0.001). After parturition, T, levels in the three groups differed significantly from each other ( F (2,26) = 26.60, p < 0.001). T, treatment significantly attenuated maternal T,, resulting in levels higher than in the MMI group but lower than in controls (Table 1) . Experiment 2. Tail blood T, concentrations were not significantly different in the three groups before mating (Table 1) . However, after parturition, MMI-alone-treated rats had significantly lower T, levels than water-drinking and MMI + T,-drinking rats ( F (2,17) = 8.30, p < 0.01). Paired t tests further showed that although the MMI-treated group showed a significant reduction in blood T, levels from the first to the second measurement (t (8) = 8.22, p < 0.01), the slight reductions evident in the control and MMI + T, groups were not significant ( p > 0.25). Thus, L-T4 in the drinking water corrected the rat dams' MMI-induced hypothyroxinemia.
Neonatal T, Levels
Experiment 1. The blood T, levels of newborn pups differed significantly between the two prenatal treatment groups (F (2,54) = 11.61, p < 0.001). Prenatal T, treatment resulted in /clLj ($rat clams, before ~ncltirzg, on gestntior~ d 16 arid ufter pcrrturitioi~, arzcl ($the ne~vhor.iz /111/1 .s :: Significantly lower than controls (watcr).
t Significantly lower than the MMI + T, group.
: I Significantly higher than the MM1-alone group. corrected neonatal T, levels: although thc MMI group had significantly lowcr levels than controls, the MMI + T,-treated group had lcvels that did not diffcr from controls (Table 1) .
Experiment 2. Trunk blood T, lcvcls in the pups born to dams that rcccived MMI + T, or watcr alone (controls) were not significantly different; T, levels of both these groups were significantly higher than in the MMI-alone group ( F (2,38) = 5.41, p < 0.01; Table 1 ). Thus, orally ingested L-T4 in the MMI-treated prcgnant rat reaches the fetus and significantly incrcascs the newborn's blood T, levels, correcting the nconate's hypothyroxincmia.
Maternal Weight and Fertility
Experimeizt 1. At the start of the cxpcriment (G-10), there was no significant differencc between the body weights of the prcgnant dams in the three groups (Table 2 ). After 6 d of drinking MMI, the mean increase in body weight was lesser for the MMI-treated rats than for controls, but the difference was not statistically significant ( p < 0.1). After parturition, the MMI-only treated group wcighed significantly less than thc controls, although the weight of thc MMI + T, postpartum dams did not differ from that in the other two groups ( F (2,28) = 3.99,/7 < 0.05).
Thc mcan number of pups dclivcrcd per litter (live and dead births), their sex ratio, and mean body or tail length wcre not significantly different in the threc groups (Table 2) . Thc mcan body weight of thc pups born in the control group was significantly greater than the weight of the pups treated with MMI.
In contrast, the weight of the newborns in the MMI + T, group was not significantly reduced compared with the controls (F (2,28) = 3.448, p < 0.05). The pups of the threc groups differed in their wcight/lcngth ratio (F (2,28) = 4.58, p < 0.05): the two MMI-treated groups were less obcsc than the control group. Experiment 2. Thc body weight of pregnant dams did not diffcr significantly bctwccn thc three groups on any of thc days of prcgnancy (Table 2) . Howcvcr, the groups showed a significantly diffcrent pattern of weight gain over this period. Specifically, between d G-10 and G-16, thc two MMI-trcated groups gained significantly less than did thc controls (F (2,lh)
The threc treatment group.; did not differ significantly in mcan numbcr of pups born (live or dcad), the pups' sex ratio, body weight, length, tail length, and wcightllcngth obesity ratio.
DISCUSSION
In this study we measured T, from rat blood spotted on filter paper, using the human neonatal RIA kit. Compared with untreated pregnant rats, subjects that rcccivcd MMI in their drinking water exhibited significantly rcduccd blood T, levels. Thc T, values of both groups werc comparable to the values reported for female rats of thc same strain by the manufacturer of the RIA kit. We also found high intraassay (duplicates), intcrassay, and intermethod (plasma-filtcr paper) correlations.
Daily i.p. administration of I.-T, from G-16 until parturition significantly increased filter paper T, levels in MMI-drinking rats. This shows that the cxogcnous T, reached the maternal circulation. This increase was also obscrvcd in rats that received T, orally in thc drinking water from G-10 until parturition.
The main goal of this study was to design a minimally invasive model for cxamining whether T, administcrcd to the dam during gestation would reach the fetus and be dctcctablc, in the newborns' circulation, by the simplest mcthod. The results show that MMI-induced intrauterine hypothyroidism, at least as evidenced by low T, levels in the newborns' blood (hypothyroxinemia), can be corrected by prenatal treatment of the mother with T,. A similar pattern of results was obtaincd by i.p. and oral routcs of administration. These findings cxtcnd the report by Calvo et nl. (5) that s.c. infusion of increasing doses of T, into MMI-treated pregnant rats preferentially protected the brain of thc hypothyroid fetus from T3 dcficicncy, whereas fetal plasma T, lcvcls increased to a lesser dcgrcc. Taken together, these findings suggest the possibility that augmentation of the pregnant mothcr's circulating T, levels SACK ET AL. ?-Significantly lower than controls.
$ Mean body weightimean body length. may also serve to prevent the detrimental developmental (physiologic, behavioral, and cognitive) outcomes of in utel-o hypothyroidism. Further work with animal models with goitrogens, such as MMI and propylthiouracil, is needed first. The current method providcs a minimally invasive way to examine this issue.
A number of important limitations exist in the current study. First, one should be aware that the finding of significant maternal-fetal T, transfer was obtained in MMI-drinking pregnant rats. Although we do not have evidence, it is still possible that MMI alters the permeability of the placenta to T, and that the results would be different in rats treated with other goitrogens or, more importantly, in naturally hypothyreotic rats. This qualification holds equally for reports from other laboratories, on maternal-fetal T, transfer in MMI-drinking pregnant rats (e.g. see Refs. 5-7 and 16). Second, the doses of T, used in this study were not very low, and the efficacy of lower doses, in the 1 pglkg range, should be examined in future studies. We note, however, that the current doses were identical to some cases and very close to others, in which T, replacement therapy was given prenatally (18) or postnatally (19) . Furthermore, as mentioned above, Calvo et al. (5) reported that the fetal brain apparently preferentially absorbs the T, transferred from the mother. It is therefore likely that higher doses are needed to correct the peripheral deficiency in T,. It is relevant also that the doses of T, administered in the current study did not prevent body weight increase during the pregnancy of the MMI-treated dams, did not decrease litter size, and did not produce excessive blood T, levels in the dams. It is possible, even so, that lower doses of I.-T, would have yielded similar results. Third, a portion of the effects of MMI in the current study may be attributed to prenatal "starvation" or undernutrition. After parturition, both the dams and the pups treated prenatally with MMI (and not "corrected" with T,) weighed significantly less than controls. A prenatally "pair-fed" control group would have helped clarify the extent of the impact of this factor on the current results. And fourth, the validity of the rat (MMI) model for studying treatment of in utero hypothyroidism in humans should not be taken for granted.
The animal model provides a number of advantages that allow for further progress of research in this field. To our knowledge, this is the first study to examine maternal-fetal T, T, TREATMENT OF IN UTERO HYPOTHYROIDISM 501 transfer in rats whose pregnancies are carried to term, and the 5. Calvo R, Ohregon MJ, Ruiz dc Ona C, Escohar dcl Rey F, Morrcale dc Escohar G 1990 Congenital hypothyroidism as studied in rats. here) opens up the opportunity to conduct long-term, postnatal making it necessary to kill only one pup at a given time. This can allow the rest of the litter to develop, enabling the assessment of the behavioral and physiologic consequences of prenatal insult and therapy. Furthermore, this type of study need not be restricted to T,: as in humans, blood spots on filter paper can be used in rats to assay levels of other hormones, e.g. TSH, 17-OH-progesterone, and cortisol (14, 20, 21) .
In conclusion, we report a convenient and minimally invasive rat model that will enable future postnatal studies examining whether maternal-fetal T, transfer can correct the detrimental effects of in utero hypothyroidism.
